Suchergebnisse - "Sasaki, Mitsuhito"

PubPharm (70)

1

Covered self-expandable metallic stent placement for tumor bleeding from duodenal invasion in patients with unresectable pancreatic cancer

enthalten in: DEN open | 2024

von Shibuki, T. | Fukushi, K. | Inoue, K. | +7

2

Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites

enthalten in: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al. | 2024

von Inoue, K. | Fukushi, K. | Yamaguchi, S. | +8

3

Covered self‐expandable metallic stent placement for tumor bleeding from duodenal invasion in patients with unresectable pancreatic cancer

enthalten in: DEN Open | 2024

von Shibuki, T. | Fukushi, K. | Inoue, K. | +7

4

Correction : Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study

enthalten in: Radiation oncology (London, England) | 2023

von Shibuki, T. | Sasaki, M. | Yamaguchi, S. | +12

ErratumFor: Radiat Oncol. 2023 Oct 31;18(1):178. - PMID 37907912

5

Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer : a single-center retrospective study

enthalten in: Radiation oncology (London, England) | 2023

von Shibuki, T. | Sasaki, M. | Yamaguchi, S. | +12

ErratumIn: Radiat Oncol. 2023 Dec 12;18(1):199. - PMID 38111062

6

Clinical course of anorexia-cachexia according to type of first-line chemotherapy for advanced pancreatic cancer

enthalten in: ResearchSquare.com | 2023

von Mitsunaga, S. | Okada, M. | Ohba, A. | +6

7

Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer

enthalten in: Cancer science | 2023

von Mitsunaga, S. | Ikeda, M. | Imaoka, H. | +14

8

FOLFIRINOX in Pancreatic Cancer : Risk Factors for Febrile Neutropenia and Severe Neutropenia - Nationwide Study Analysis

enthalten in: Anticancer research | 2023

von Todaka, A. | Sasaki, M. | Ueno, H. | +14

9

Case Report : Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma

enthalten in: Frontiers in oncology | 2023

von Satake, T. | Shibuki, T. | Watanabe, K. | +5

10

Safety and efficacy of S-IROX (S-1, irinotecan and oxaliplatin combination therapy) in patients with advanced pancreatic cancer : A multicenter phase 1b dose-escalation and dose-expansion clinical trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Ohba, A. | Ueno, H. | Shiba, S. | +13

1
2
3
4
5
6
7
Nächster »
[7]